SS Innovations

SS Innovations announced today that surgeons successfully performed a mitral valve replacement using its surgical robot.

The procedure marks the world’s first mitral valve replacement using the company’s Mantra surgical robot. It took place at the Narayana Hrudayalaya Institute of Cardiac Sciences in Bengaluru, India. Dr. Nitin Kumar Rajput performed the surgery, guided by Dr. Sudhir Srivastava, SS Innovations’ founder and chair.

Mantra, the first surgical robot made in India, according to a news release, offers a cost-effective option for a range of surgical applications. It already has regulatory approval in India, Indonesia and Guatemala. SS Innovations already initiated the regulatory process in the U.S. and Europe as well. It hopes for approvals in the latter half of 2024 or 2025.

The system provides capabilities for multi-specialty uses. Its uses span cardiothoracic, head and neck, gynecology, urology, general surgery and more. Th…

SS Innovations announced today that it filled the first international order for its SSi Mantra surgical robot platform.

Fort Lauderdale, Florida-based SS Innovations delivered the unit to Aster Hospital in Dubai, United Arab Emirates. Aster DM Healthcare Limited — which operates 32 hospitals and other healthcare facilities in six countries — part-operates that hospital.

Designed to support advanced, affordable and accessible robotic surgery, SSi Mantra provides capabilities for multi-specialty uses. Its uses span cardiothoracic, head and neck, gynecology, urology, general surgery and more. The system features a modular, 3D vision, open-console design with superior ergonomics. It engages machine learning models to improve safety and efficiency during procedures.

News of the sale follows the company’s announcement last week that began work on regulatory submissions for SSi Mantra. SS Innovations already received regulatory approval from Indian author…

SS Innovations announced today that it commenced the process of applying for regulatory approvals for its surgical robot device.

Fort Lauderdale, Florida-based SS Innovations plans to apply for FDA approval and CE mark for its flagship SSi Mantra device. It retained regulatory and quality compliance firm Elexes for support through the approval process.

The company said in a news release that SSi Mantra is one of the only systems in the world to be distinctly cost-effective with broad-spectrum surgical applications. That includes cardiac surgery. SS Innovations already received regulatory approval from Indian authorities and validated the system in more than 40 different procedures.

Designed to support advanced, affordable and accessible robotic surgery, SSi Mantra provides capabilities for multi-specialty uses. Its uses span cardiothoracic, head and neck, gynecology, urology, general surgery and more. The system features a modular, 3D vision, open-consol…